Tag: TGA

Therapeutic Goods Administration requests additional clinical data on Mainstay Medical’s ReActiv8

Mainstay Medical, a medical device company focused on bringing to market ReActiv8, an implantable restorative neurostimulation system to treat disabling chronic low back pain,...
Providence DTRAX

Australian regulatory body approves Providence’s DTRAX line

Providence Medical Technology, a developer of cervical spine technology, has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for its DTRAX line...

ApiFix spinal implant receives Australian Therapeutic Goods Administration certification

ApiFix has received Australian Therapeutic Goods Administration certification through its distributor, Orthotech. The ApiFix system will now be marketed in Australia for the treatment and...